HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TWINBEECH CAPITAL LP 180,520$6,895,8640.13%
Y-Intercept (Hong Kong) Ltd 35,174$1,343,6470.13%
EAGLE ASSET MANAGEMENT INC 575,204$21,972,7920.13%
CAMPBELL NEWMAN ASSET MANAGEMENT INC 34,061$1,301,1300.12%
Arbor Investment Advisors, LLC 17,950$685,6900.12%
Alliance Wealth Advisors, LLC /UT 8,389$320,4600.12%
GLOBEFLEX CAPITAL L P 25,980$992,4360.12%
CIM INVESTMENT MANAGEMENT INC 7,991$305,2560.11%
Dynamic Technology Lab Private Ltd 29,191$1,1150.11%
Trexquant Investment LP 114,663$4,380,1270.11%
Engineers Gate Manager LP 72,883$2,784,1310.10%
CONGRESS ASSET MANAGEMENT CO /MA 303,717$11,601,9890.10%
Boussard & Gavaudan Investment Management LLP 21,964$858,5730.10%
SEGALL BRYANT & HAMILL, LLC 218,405$8,343,0710.10%
PROFUND ADVISORS LLC 44,252$1,690,4260.09%
Candriam S.C.A. 331,141$12,649,5860.09%
Bison Wealth, LLC 12,143$463,8630.09%
CORNERCAP INVESTMENT COUNSEL INC 12,161$464,5500.08%
Epoch Investment Partners, Inc. 331,834$12,676,0590.08%
FULLER & THALER ASSET MANAGEMENT, INC. 368,394$14,072,6430.08%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.